New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 11, 2012
19:56 EDTHZNPHorizon presents data showing effectiveness of RAYOS
Horizon Pharma announced an additional analysis of data from the pivotal Circadian Administration of Prednisone in Rheumatoid Arthritis-2, CAPRA-2, clinical trial demonstrating that patients with active rheumatoid arthritis (RA) treated with its recently approved RAYOS 5 mg (prednisone) delayed-release tablets had a significant improvement in reduction of fatigue, as determined by the Functional Assessment of Chronic Illness Therapy - Fatigue, FACIT-F, questionnaire. Data were presented during the American College of Rheumatology, ACR/Association of Rheumatology Health Professionals,ARHP, Annual Scientific Meeting in Washington, D.
News For HZNP From The Last 14 Days
Check below for free stories on HZNP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 13, 2014
07:32 EDTHZNPHorizon Pharma, POZEN announce USPTO Notice of Allowance for VIMOVO
Subscribe for More Information
August 8, 2014
10:34 EDTHZNPOptions with decreasing implied volatility
Subscribe for More Information
07:35 EDTHZNPHorizon announces S-4 registration statement for Vidara declared effective
Subscribe for More Information
August 7, 2014
17:13 EDTHZNPVisium reports 5.5% passive stake in Horizon Pharma
Subscribe for More Information
10:20 EDTHZNPHigh option volume stocks
Subscribe for More Information
09:08 EDTHZNPOn The Fly: Pre-market Movers
Subscribe for More Information
06:46 EDTHZNPHorizon Pharma sees FY15 revenue $380M-$405M, consensus $351.77M
Subscribe for More Information
06:45 EDTHZNPHorizon Pharma backs FY14 revenue guidance of $270M-$280M, consensus $268.95M
Backs adjusted EBITDA guidance of $80M-$90M.
06:43 EDTHZNPHorizon Pharma reports Q2 adjusted EPS 21c, consensus 10c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use